IGC Pharma (IGC) Receivables - Other (2011 - 2026)
IGC Pharma (IGC) reported Receivables - Other of $657000.0 for Q1 2026, down 3.38% year-over-year from $680000.0 in Q1 2025, and down 1.5% quarter-over-quarter from $667000.0 in Q4 2025.
IGC Pharma (IGC) Receivables - Other (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Receivables - Other data on file, last reported at $657000.0 in Q1 2026.
- Receivables - Other for Q1 2026 came in at $657000.0, down 3.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $657000.0 (down 3.38% YoY), and the FY2026 annual result was $657000.0, down 3.38% from the prior year.
- Receivables - Other fell to $657000.0 in Q1 2026 per IGC's latest filing, from $667000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $951000.0 in Q1 2023 and troughed at $354000.0 in Q2 2022.
- A 5-year average of $712294.1 and a median of $685000.0 in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other jumped 168.64% in 2023, then declined 28.22% in 2024.
- A 5-year view of Receivables - Other shows it stood at $751000.0 in 2022, then gained by 25.97% to $946000.0 in 2023, then decreased by 28.22% to $679000.0 in 2024, then fell by 1.77% to $667000.0 in 2025, then decreased by 1.5% to $657000.0 in 2026.
- Business Quant data shows IGC's Receivables - Other at $657000.0 in Q1 2026, $667000.0 in Q4 2025, and $670000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 657,000.00 |
| Mar 31, 2026 | 657,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Jun 30, 2025 | 680,000.00 |
| Mar 31, 2025 | 680,000.00 |
| Mar 31, 2025 | 680,000.00 |
| Dec 31, 2024 | 679,000.00 |
| Dec 31, 2024 | 679,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Jun 30, 2024 | 686,000.00 |
| Mar 31, 2024 | 686,000.00 |
| Mar 31, 2024 | 686,000.00 |
| Dec 31, 2023 | 946,000.00 |
| Dec 31, 2023 | 946,000.00 |